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ABSTRACT Mitochondria located within neuronal presynaptic terminals have been shown to play
important roles in the release of chemical neurotransmitters. In the present study, a genetic screen for
synaptic transmission mutants of Drosophila has identiﬁed the ﬁrst mutation in a Drosophila homolog of the
mitochondrial protein P32. Although P32 is highly conserved and has been studied extensively, its phys-
iological role in mitochondria remains unknown and it has not previously been implicated in neural function.
The Drosophila P32 mutant, referred to as dp32EC1, exhibited a temperature-sensitive (TS) paralytic behav-
ioral phenotype. Moreover, electrophysiological analysis at adult neuromuscular synapses revealed a TS
reduction in the amplitude of excitatory postsynaptic currents (EPSC) and indicated that dP32 functions in
neurotransmitter release. These studies are the ﬁrst to address P32 function in Drosophila and expand our











Previous studies have established important functions for mitochon-
dria in synaptic transmission. A key aspect of this work has focused on
the roles of mitochondria in providing energy for synaptic function
[reviewed in Kann and Kovács (2007) and Mattson et al. (2008)].
Moreover, mitochondria are known to sequester and release calcium,
and earlier studies have addressed roles for these mechanisms in pre-
synaptic calcium signaling and neurotransmitter release (Billups and
Forsythe 2002; Chouhan et al. 2010; David and Barrett 2003; Klose
et al. 2009; Tang and Zucker 1997; Yang et al. 2003). This progress,
along with recent work implicating mitochondrial mechanisms
in neurological disease [reviewed in Mattson et al. (2008), Rezin
et al. (2009), Schon and Przedborski (2011), Vos et al. (2010), and
Whitworth and Pallanck (2009)], highlights the importance of un-
derstanding the molecular basis of mitochondrial function in synaptic
transmission. The present study advances our understanding through
identiﬁcation of the ﬁrst P32 mutant in a multicellular organism and
by revealing a novel role for this mitochondrial protein in neurotrans-
mitter release.
P32 was ﬁrst identiﬁed in HeLa cells as a protein associated with
the splicing factor ASF/SF2 (Krainer et al. 1991), and it was found to
be conserved among eukaryotic organisms (Muta et al. 1997). Al-
though many studies employing immunocytochemical and subcellular
fractionation analysis have shown that P32 is primarily localized in the
mitochondrial matrix (Dedio et al. 1998; Muta et al. 1997; Seytter et al.
1998), its expression in other compartments, including the extracel-
lular cell surface, has been reported (Fogal et al. 2008; Ghebrehiwet
et al. 2001; Majumdar et al. 2002; Matthews and Russell 1998). The
crystal structure of P32 has provided valuable information (Jiang et al.
1999). Three P32 molecules form a doughnut-shaped homotrimeric
structure that displays an unusually asymmetric charge distribution
such that one surface of the doughnut is covered with negatively
charged residues. On the basis of this structural information, the
authors proposed that P32 may serve as a high-capacity divalent
cation-binding protein within the mitochondrial matrix, may associate
with the inner mitochondrial membrane in the presence of divalent
metal ions or even regulate pore opening of channels in the inner
mitochondrial membrane.
Previous studies have suggested P32 may function in a wide variety
of processes, including RNA splicing (Krainer et al. 1991), comple-
ment system signaling [reviewed in Ghebrehiwet et al. (2001)], cell
polarity determination (Bialucha et al. 2007), mitochondrial oxidative
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Volume 2 | January 2012 | 59phosphorylation (Fogal et al. 2010; Muta et al. 1997) and apoptosis
(Itahana and Zhang 2008; Rizvi et al. 2011; Sunayama et al. 2004). In
addition, several studies have reported binding interactions of P32
with viral proteins (Beatch and Hobman 2000; Bruni and Roizman
1996; Luo et al. 1994; Matthews and Russell 1998; Wang et al. 1997;
Yu et al. 1995). The ﬁrst genetic analysis of P32 was carried out in
yeast and led to contradictory conclusions with regard to P32 function
in regulating oxidative phosphorylation (Muta et al. 1997; Seytter et al.
1998); thus, the physiological role of P32 in mitochondria remains
unclear. To date, a major limitation in studies of P32 function has
been the lack of mutants in multicellular model organisms. The pres-
ent study reports identiﬁcation and characterization of a Drosophila
P32 mutant and further deﬁnes the molecular basis of mitochondrial
function in neurotransmitter release.
MATERIALS AND METHODS
Drosophila strains
cacTS2, Appl-GAL4,a n delav-GAL4 Appl-GAL4 were from our labora-
tory stock collection. The UAS-mito-GFP and UAS-mCD8-mRFP
transgenic lines were obtained from the Bloomington Stock Center.
Deﬁciency lines Df(2R)14F06W-06, Df(2R)14F06W-07, Df(2R)
14F06W-08,a n dDf(2R)14F06W-09 were generously provided by
William Gelbart (Harvard University). A third chromosome 20xUAS-
GCaMP3 line was kindly provided by Loren Looger [(Janelia Farm
Research Campus, Howard Hughes Medical Institute (HHMI)]. UAS-
YC3.6, UAS-mito-DsRed, UAS-dp32, UAS-dp32-EGFP,a n dUAS-mito-
GCaMP3 transgenic lines were generated in the current study (see
Generation of Transgenic Lines). Wild-type ﬂies were Canton-S. Stocks
and crosses were cultured on a conventional cornmeal-molasses-yeast
medium at 20 .
Mutagenesis and screening
To isolate new mutations that enhance or suppress the cacTS2 paralytic
phenotype, a genetic screen was carried out as summarized in Figure
S1.B r i e ﬂy, cacTS2 males with an isogenized second chromosome were
exposed for 24 hr to 25 mM ethyl methanesulfonate (EMS) (Dellinger
et al. 2000). F3 ﬂies homozygous for a mutagenized second chromo-
some in a cacTS2 genetic background were screened for altered cacTS2
behavior at 36  as described previously (Brooks et al. 2002; Kawasaki
et al. 2011).
Molecular characterization of the dp32 mutant
Sequence analysis of candidate genes was carried out essentially as
described previously (Kawasaki et al. 2011). Brieﬂy, genomic DNA
was prepared from the dp32 mutant or ﬂies carrying the parent second
chromosome used in the mutagenesis. This was used as template for
PCR, and gel-puriﬁed PCR products were sequenced at the Penn State
University Nucleic Acids Facility.
Generation of transgenic lines
Transformation constructs for UAS-YC3.6, UAS-mito-DsRed, UAS-
dp32,a n dUAS-dp32-EGFP transgenic lines were generated by insert-
ing the respective open reading frame (ORF) for YC3.6 (Nagai et al.
2004), dP32 (cDNA accession number AY094810), or dP32 with
EGFP fused to its C-terminus, into the P element transformation
vector, pUAST (Brand and Perrimon 1993). For UAS-mito-DsRed
and UAS-mito-GCaMP3, a mitochondrial targeting sequence was
fused to the N-terminus of the DsRed (Baird et al. 2000) or GCaMP3
(Tian et al. 2009) ORFs. For UAS-mito-DsRed, the mitochondrial
targeting sequence corresponded to the mitochondrial targeting do-
main of the human COX8 protein (Rizzuto et al. 1995). For UAS-
mito-GCaMP3, the mitochondrial targeting sequence corresponded to
amino acids 1-71 of the dP32 N-terminus. Generation of transgenic
lines was achieved as described previously (Kawasaki et al. 2004). A
cDNA clone for Drosophila gene CG6459, which we renamed dp32,
was obtained from the Drosophila Genomics Research Center (Clone
ID: LD29590). Neural expression of UAS transgenes was achieved
using the Appl-GAL4 driver or an elav-GAL4 Appl-GAL4 double
driver chromosome in the case of experiments for rescue of the
dp32EC1 mutant behavioral phenotype.
Generation of a polyclonal anti-dP32 antibody
A rabbit polyclonal antiserum, anti-dP32, was generated against
a synthesized peptide corresponding to the C-terminus of the dP32
sequence (amino acids 246–263; Figure 3) as in our previous work
(Zou et al. 2008). Through a commercial service (Pocono Rabbit Farm
and Laboratory, Canadensis, PA), the peptide was synthesized with
cysteine appended at the N-terminus and prepared for injection by
conjugation with keyhole-limpet hemocyanin (KLH).
Western analysis
Western analysis of head homogenates was performed using
conventional methods as described previously (Kawasaki et al.
2004; Zou et al. 2008). Brieﬂy, the equivalent of one ﬂy head was
loaded per lane on a 12% SDS-PAGE gel. The primary antibodies,
a rabbit polyclonal anti-dP32 antibody and a monoclonal anti-GFP
antibody (Clontech, Mountain View, CA), were used at a dilution of
1:1,000. Detection was performed with horseradish peroxidase
(HRP)-conjugated secondary antibodies (Amersham Biosciences,
Arlington Heights, IL) and enhanced chemiluminescence (ECL Plus
Western Blotting Detection System; Amersham Biosciences). Tubulin
served as loading control and was detected using a monoclonal anti-
acetylated a-tubulin antibody (Sigma, St. Louis, MO) at a dilution of
1:2,000,000.
For developmental Western blots, Drosophila embryos were col-
lected every 4 hr in large culture cages and allowed to develop to the
appropriate stage. Whole-animal homogenates were generated from
several developmental stages. The amount of homogenate loaded per
lane was a follows: early or late embryos (11 embryos), third instar
larvae (the equivalent of 0.1 bodies), late pupae (the equivalent of 0.09
bodies), and adults (the equivalent of 0.1 bodies). The rabbit poly-
clonal anti-dP32 antibody and the monoclonal anti-acetylated
a-tubulin antibody (Sigma) were used at a dilution of 1:1,000 and
1:200,000, respectively. For quantitation of Western blots, ECL signal
intensities were measured using a Storm 860 Imaging System (GE
Healthcare, Piscataway, NJ).
Coimmunoprecipitation analysis
Coimmunoprecipitation (Co-IP) analysis was carried out essentially as
described previously (Zou et al. 2008). Fly head lysate was prepared
from transgenic ﬂies expressing dP32-EGFP or Canton-S controls.
Five hundred microliters of lysate equivalent to 50 heads and 5 mg
of a rabbit polyclonal anti-GFP antibody (Invitrogen, Carlsbad, CA)
were incubated with 50 mlo fa5 0 %s l u r r yo fP r o t e i nA –Sepharose
beads (Amersham Biosciences). After washing, beads were pelleted,
resuspended in 20 ml of SDS sample buffer, and boiled for 3 min to
elute proteins. For detection of dP32-EGFP (IP) and endogenous
dP32 (co-IP), 2.5 mlo r5mlo ft h e2 0ml IP sample was loaded per
lane, respectively. After electrophoresis, gels were processed for West-
ern blot analysis.
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Immunocytochemistry and confocal microscopy were performed
essentially as described previously (Kawasaki et al. 2011; Kawasaki
and Ordway 2009). These studies employed the following primary
antibodies: rabbit anti-SYT Dsyt CL1 (1:5,000) [Noreen Reist (Colo-
rado State University, Fort Collins, CO)]; mAb nc82 anti-BRP
(BRUCHPILOT) (1:50) [Erich Buchner (Universitaet Wuerzburg,
Germany)]; rabbit anti-GFP (1:1,000) (Invitrogen); Cy5-conjugated
rabbit anti-HRP (1:200) (Jackson Immunoresearch Laboratories,
West Grove, PA). Secondary antibodies included Alexa Fluor 488-
conjugated anti-mouse IgG (1:200) and Alexa Fluor 568-conjugated
anti-rabbit IgG (1:200) (Invitrogen). Adult dorsal longitudinal ﬂight
muscle (DLM) neuromuscular synapse preparations were imaged
using an Olympus FV1000 confocal microscope (Olympus Optical,
Tokyo, Japan) with a PlanApo 60· 1.4 numerical aperture oil ob-
jective (Olympus Optical) and a z-step size of 0.2 mm. Images were
obtained and processed with Fluoview software (Olympus Optical).
All images shown in ﬁgures are maximum projections of two con-
secutive optical z-sections.
Synaptic electrophysiology
Excitatory postsynaptic currents (EPSC) were recorded at DLM
neuromuscular synapses of 3- to 5-day-old adults reared at 20 .S a l i n e
solution consisted of (in mM): 128 NaCl, 2 KCl, 4.0 MgCl2, 1.8 CaCl2,
5 HEPES, and 36 sucrose. The pH was adjusted to 7.0 using NaOH.
Recordings at 33  and 36  were obtained after exposure to these
temperatures for 7 min. These experiments were performed as de-
scribed previously (Kawasaki and Ordway 2009).
ATP measurements
Flies were exposed to 38 , a restrictive temperature for the dp32EC1
mutant, for 3 min and then frozen in liquid nitrogen. Heads were
separated from bodies as described (Zou et al. 2008), and 10 heads
were homogenized in 100 ml of 5 M Guaindine-HCl. The homoge-
nates were then boiled for 3 min, followed by centrifugation in
a microcentrifuge at 14,000 rpm for 3 min. The supernatant was used
to measure the ATP concentration using a bioluminescence assay
(ATP Determination Kit; Invitrogen) according to the manufacturer’s
instructions. Luminescence was measured by a luminometer (Packard
Instrument Co., Meriden, CT). Brieﬂy, the supernatant was diluted
20-fold with dH2O, and 20 ml of diluted supernatant was dispensed
into each well of a luminometer 96-well plate, followed by mixing with
180 ml of the luciferase assay reagent. The resulting luminescence was
compared with standards provided by the manufacturer to determine
the ATP concentration. The relative ATP level was calculated by di-
viding the ATP concentration by the protein concentration, which
was determined by the Bradford method (Coomassie Plus Protein
Assay; Thermo Scientiﬁc, Waltham, MA). For the Bradford assay,
supernatants were diluted 5-fold with dH2O.
Live imaging
Imaging of TMRE, YC3.6, and GCaMP3 in the DLM presynaptic
terminal was performed using an Olympus FV1000 confocal micro-
scope with a LUM Plan 60X 1.0-NA water immersion objective
(Olympus Optical) as described previously (Danjo et al. 2011).
For TMRE imaging, the DLM preparations were incubated in
saline solution containing 5 nM TMRE for 10 min prior to image
acquisition. Imaging at 36  was started after 5 min at 36 . The mito-
chondrial TMRE ﬂuorescence within DLM nerve terminals was iden-
tiﬁed by colocalization with the mitochondrial marker, mito-GFP,
expressed presynaptically, and the GFP-ﬂuorescence intensity was
used to normalize the TMRE signal. The GFP and TMRE imaging
settings (excitation, dichroic, emission) were as follows: GFP (488 nm,
SDM560, BA505-525); TMRE (543 nm, Mirror, BA560-660).
For calcium imaging using YC3.6, GCaMP3, and mito-GCaMP3,
neuronal-speciﬁc expression of the membrane-associated mCD8-mRFP
protein provided a red ﬂuorescent marker for nerve terminals. The YC3.6
and GCaMP3 imaging settings (excitation, dichroic, emission) were as
follows: YC3.6 (CFP, 458 nm, SDM510, BA480-495; YFP, 458 nm,
Mirror, BA535-565); GCaMP3 (488 nm, SDM560, BA505-525). Time-
lapse imaging was performed continuously at rates of 200 msec per frame.
To minimize muscle movement during stimulation, the DLM muscle
ﬁbers were depolarized by impaling them with a sharpened tungsten wire.
Images were processed using Metavue software (Molecular
Devices, Sunnyvale, CA). All image analysis was done after back-
ground subtraction. The average ﬂuorescent intensity during a 2 sec
interval before stimulus onset (F) and changes in the intensity at
a given time point (DF) provide a measure of relative calcium con-
centration changes (DF/F). For live imaging experiments, data were
obtained from at least ﬁve preparations.
Data analysis
Microsoft (Seattle, WA) Excel was utilized to analyze numerical data
and generate graphs. All data values are presented as mean 6 SEM.
Statistical signiﬁcance was determined using the two-tailed Student
t-test, and signiﬁcance was assigned to comparisons for which P # 0.05.
RESULTS
A genetic modiﬁer screen identiﬁes a second
chromosome enhancer of cacTS2
Our previous genetic analysis has employed phenotypic screens to
identify new mutants affecting synaptic transmission. The TS pre-
synaptic calcium channel mutant cacTS2 was recovered in a screen for
genetic modiﬁers of comatose, a TS synaptic transmission mutant in
the N-ethylmaleimide sensitive factor 1 (dNSF1) gene (Dellinger et al.
2000; Kawasaki et al. 2000, 2002). A subsequent screen for modiﬁers
of cacTS2 identiﬁed intragenic mutations that enhance or suppress
cacTS2 as well extragenic enhancers in other genes (Brooks et al.
2003; Kawasaki et al. 2011). Here we extend this genetic analysis
through identiﬁcation of a new extragenic enhancer of cacTS2, e(cac)
2902. On the basis that cacTS2 is paralyzed rapidly at 38  but exhibits
only mild motor defects at 36 , we carried out a forward genetic
screen for second chromosome enhancers of the cacTS2 behavioral
phenotype at 36  (Figure S1). Unlike cacTS2 alone, the cacTS2; e(cac)
2902 double mutant exhibits rapid paralysis at 36  (Figure 1A). This
enhancer phenotype was shown to be recessive when the e(cac)2902
mutation was made heterozygous in a cacTS2 mutant background.
Furthermore, after the e(cac)2902 mutation was separated from cacTS2,
it exhibited a TS paralytic phenotype by itself (Figure 1B). Thus e(cac)
2902 represents a new TS paralytic mutation identiﬁed as an enhancer
of the presynaptic calcium channel mutant cacTS2.
A synaptic phenotype in the e(cac)2092 mutant
To examine whether e(cac)2902 enhanced the cacTS2 synaptic pheno-
type, electrophysiological recordings were performed at adult DLM
neuromuscular synapses (Kawasaki and Ordway 2009). As described
previously (Kawasaki et al. 2000) and as shown in Figure 2, synaptic
transmission in cacTS2 was normal at the permissive temperature of
20 .A t3 6  , cacTS2 exhibited a marked reduction in the EPSC ampli-
tude with respect to wild-type. In a cacTS2 genetic background, the
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producing a greater EPSC amplitude reduction than in cacTS2 alone
(Figure 2). Furthermore, the isolated e(cac)2902 mutation in a cac+
genetic background produced a TS reduction in the EPSC amplitude
similar to that observed in cacTS2 (Figure 2). Both the TS synaptic and
paralytic phenotypes of e(cac)2902 recovered upon return to the per-
missive temperature. The preceding observations indicate that the
e(cac)2902 gene product serves an important function in synaptic
transmission.
Mapping and molecular identiﬁcation of e(cac)2092:
a new P32 mutant
To determine the location of e(cac)2902 on the second chromosome,
meiotic recombinational mapping was conducted in a cacTS2 genetic
background using four visible phenotypic markers, Sternopleural (Sp),
Scutoid (Sco), Lobe (L), and Pin. Initial mapping indicated that e(cac)
2902 lies approximately 15 map units to the right of Lobe. Therefore,
deﬁciency mapping of the recessive e(cac)2092 enhancer phenotype
was carried out using deﬁciency chromosomes covering this region
(Figure 3A). Because Df(2R)14F06W-06 complemented e(cac)2902,
whereas Df(2R)14F06W-07 did not, the e(cac)2902 mutation was
placed within a 9 kb region of the second chromosome containing
only four candidate genes (Figure 3A).
The molecular lesion in e(cac)2902 was identiﬁed by sequence
analysis. For each of the four candidate genes, protein coding sequen-
ces were determined from the e(cac)2902 mutant as well as the unmu-
tagenized “parent” chromosome (Figure 3B). The only sequence
change identiﬁed in the mutant was within the ORF of CG6459.T h i s
mutation was absent in the parent chromosome sequence and thus
was likely induced by the mutagenesis. CG6459 encodes a homolog of
the evolutionarily conserved mitochondrial protein P32, which we
have named dP32. Accordingly, the e(cac)2902 mutant has been
renamed dp32EC1 (EC1, enhancer of cacTS2 1). The dp32EC1 mutation
introduces a stop codon that truncates dP32 after 101 amino acids
(Figure 3) and likely represents a complete loss-of-function mutation.
This observation suggests the TS paralytic phenotype of dp32EC1 does
not reﬂect a conditional disruption of dP32 activity but, rather, a role
for dP32 in an inherently TS process affecting synaptic transmission.
Comparison of vertebrate and Drosophila P32 protein sequences
revealed a high degree of conservation (Figure 3B). Mammalian P32 is
targeted to mitochondria by an amino terminal targeting sequence
that is cleaved to generate a mature P32 protein localized within the
mitochondrial matrix. The site of P32 proteolytic cleavage appears to
be conserved within dP32 (Figure 3B). Moreover, in the present study,
the N-terminal domain of dP32 was shown to exhibit an equivalent
mitochondrial targeting function when fused to the calcium indicator
GCaMP3 (mito-GCaMP3; Figure S2).
Figure 1 A genetic modiﬁer screen identiﬁes a second chromosome
enhancer of cacTS2. (A) e(cac)2902 is an enhancer of cacTS2. The dou-
ble mutant, w cacTS2; e(cac)2902 exhibits rapid paralysis at 36 ,
whereas cacTS2 alone does not paralyze at this temperature. Flies het-
erozygous for the enhancer mutation [w cacTS2; e(cac)2902/+]
exhibited a cacTS2 behavioral phenotype, indicating the mutation is
recessive. Behavior tests for cacTS2 and w cacTS2; e(cac)2902/+ were
truncated after 20 min. Time for 50% paralysis in the w cacTS2; e(cac)
2902 double mutant was 1.3 6 0.60 sec (n ¼ 5). (B) e(cac)2902 is a TS
paralytic mutation itself. e(cac)2902 in a cac+ genetic background
exhibits paralysis at 38 , whereas wild-type ﬂies (WT) do not paralyze.
Flies heterozygous for the e(cac)2902 mutation exhibited a wild-type
behavior, indicating the mutation is recessive. Flies carrying e(cac)2902
in trans to Df(2R)14F06W-07 exhibit the e(cac)2902 paralytic pheno-
type. Times for 50% paralysis in e(cac)2902 and e(cac)2902/Df(2R)
14F06W-07 were 9.8 6 1.77 sec (n ¼ 5) and 11.2 6 3.12 sec (n ¼ 5),
respectively. Behavioral tests for WT and e(cac)2902/+ were truncated
after 20 min. Asterisks mark values signiﬁcantly different from control
values. Here, and in subsequent ﬁgures, error bars indicate SEM, and
asterisks denote statistical signiﬁcance.
Figure 2 A synaptic phenotype in e(cac)2902. (A) Rep-
resentative excitatory postsynaptic current (EPSC)
recordings from dorsal longitudinal ﬂight muscle
(DLM) neuromuscular synapses of WT, cacTS2, w
cacTS2;e(cac)2902 double mutants, and w;e(cac)2902 at
20  and 36 . w cacTS2;e(cac)2902 exhibits a wild-type
EPSC amplitude at 20 . At the restrictive temperature
of 36 , the double mutant exhibited a stronger TS syn-
aptic phenotype than cacTS2 alone. w;e(cac)2902 in
a cac+ genetic background produced a TS synaptic phe-
notype similar to that of cacTS2. Stimulation artifacts
were removed for clarity. (B) Comparison of average
peak EPSC amplitudes at permissive and restrictive tem-
peratures. The respective mean EPSC amplitudes in
WT, cacTS2, w cacTS2;e(cac)2902, and w;e(cac)2902 at
20  were 1.65 6 0.05 mA( n¼ 25), 1.65 6 0.06 mA
(n ¼ 15), 1.56 6 0.09 mA( n¼ 5), and 1.63 6 0.04 mA
(n ¼ 7). The corresponding values at 33  were 2.01 6 0.06 mA( n¼ 49), 1.09 6 0.06 mA( n¼ 11), 0.49 6 0.15 mA( n¼ 5), and 1.72 6 0.24 mA( n¼
6). The corresponding values at 36  were 1.84 6 0.06 mA( n¼ 11), 0.51 6 0.03 mA( n¼ 8), 0.05 6 0.05 mA( n¼ 3), and 0.94 6 0.24 mA( n¼ 5).
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a role for dP32 in neurotransmitter release
For analysis of the dP32 protein, a rabbit polyclonal antiserum was
generated against a synthetic peptide corresponding to the C-terminal
18 amino acids of dP32 (Figure 3B). By Western analysis (Figure 4A),
this antiserum detected dP32 in head homogenates, indicating that
dP32 is expressed in the nervous system. Speciﬁcity of the antiserum
was demonstrated by loss of dP32 immunoreactivity in the dp32EC1
mutant (Figure 4A). These studies demonstrate that dp32EC1 lacks the
full-length dP32 protein as predicted from the underlying molecular
lesion. Our initial characterization of dP32 expression was extended
beyond the adult nervous system by conducting developmental West-
ern analysis of whole ﬂies, pupae, larvae, and embryos (Figure S3).
dP32 expression is relatively high during embryogenesis and lower in
third instar larvae. At the adult stage, more dP32 is expressed in
females compared with males. This observation, along with the high
levels of dP32 in early embryos, may reﬂect expression of dP32 in the
female reproductive system. These observations are generally consis-
tent with reported mRNA expression data (Tweedie et al. 2009).
To conﬁrm that the dP32 mutation produces the observed TS
paralytic and synaptic phenotypes, transformation rescue experiments
were carried out using the GAL4-UAS system (Brand and Perrimon
1993). UAS-dp32 transgenic lines were generated to express the wild-
type dP32 protein, and neural expression was achieved using the Appl-
GAL4 driver line as described in our previous work [cf.( K a w a s a k i
et al. 2011; Kawasaki and Ordway 2009)]. Transgene expression was
conﬁrmed by Western analysis (Figure 4A). Expression of wild-type
dP32 in the nervous system produced clear rescue of the dp32EC1 TS
paralytic phenotype (Figure 4B), demonstrating an important function
for dP32 in the nervous system. Furthermore, electrophysiological
recordings conﬁrmed that transgenic expression of wild-type P32
rescues the dp32EC1 synaptic phenotype (Figure S4).
Figure 3 A Drosophila P32 mutant. (A) Meiotic and deﬁciency mapping placed the e(cac)2902 mutation within a 9 kb region on the right arm of
the 2nd chromosome (2R). Numerical positions (in kb or bp) within the Drosophila genome sequence are indicated. The deleted region for each
deﬁciency chromosome is represented by a black or gray bar. Gray indicates that the deﬁciency chromosome failed to complement the e(cac)
2902 behavioral phenotype when in trans to the e(cac)2902 mutant chromosome. Sequencing of four candidate genes within the 9 kb region
revealed a single nucleotide deletion in the CG6459 ORF resulting in a premature stop codon. C at position 303 was deleted, and thus the
resulting codon changes are from [GCC GTA A] to [GCG TAA] (deleted nucleotide underlined; new stop codon in bold). CG6459 is a Drosophila
homolog of P32, and e(cac)2902 is now termed dp32EC1. (B) Alignment of P32 homologs from human, zebraﬁsh, and Drosophila. Amino acid
identities and similarities are shaded in black and gray, respectively. The dp32EC1 mutation introduces a premature stop codon (V102STOP; arrow
head). Human P32 is synthesized as a precursor protein, of which the ﬁrst 73 amino acids contain a mitochondrial targeting signal (Honoré et al.
1993). The mature protein is generated by site-speciﬁc cleavage after Residue 73 (broken line). The epitope for production of polyclonal antisera
against dP32 is indicated (solid line). Amino acids are numbered according to their positions in the corresponding precursor proteins. Protein
sequence accession numbers: human P32 (NP_001203), zebraﬁsh P32 (XP_001331129) and dP32 (AAM11163).
Volume 2 January 2012 | P32 Function in Synaptic Transmission | 63Localization of dP32 in mitochondria at DLM
neuromuscular synapses
Previous studies indicate that dP32 proteins are localized to
mitochondria (Dedio et al. 1998; Muta et al. 1997; Seytter et al.
1998; but see also Fogal et al. 2008; Ghebrehiwet et al. 2001; Majum-
dar et al. 2002; Matthews and Russell 1998), and the mitochondrial
targeting sequence of human P32 has been characterized (Honoré
et al. 1993). Although the anti-dP32 antibody is suitable for Western
analysis and demonstrated clear expression of dP32 in the nervous
system, the same antibody produced no signal above background in
immunocytochemical studies of dP32. Thus, UAS transgenic lines
were generated to express a form of dP32 tagged with EGFP at the
C-terminus, dP32-EGFP. Expression of dP32-EGFP in the nervous
system of dp32EC1 mutants produced rescue of TS paralysis (Figure
S5), indicating that dP32-EGFP retains its function. These develop-
ments permitted analysis of dP32 distribution in neurons. Following
neural expression of dP32-EGFP, imaging native dP32-EGFP ﬂuores-
cence at DLM neuromuscular synapses demonstrated clear mitochon-
drial localization (Figure 5).
Biochemical analysis of dP32
Understanding the mechanisms of dP32 function in mitochondria
and synaptic transmission will require deﬁning its molecular inter-
actions. Previous biochemical and structural studies have established
that P32 exhibits a homotrimeric quaternary structure (Ghebrehiwet
et al. 1994; Jiang et al. 1999). As a starting point for biochemical
analysis of dP32 in Drosophila, we examined whether analogous
homomeric interactions occur in neural tissue. These studies achieved
speciﬁc immunoprecipitation of the dP32-EGFP fusion protein using
an anti-GFP antibody. Tissue samples from wild-type ﬂies lacking
expression of the dP32-EGFP transgene served as controls. In ﬂy head
homogenates, speciﬁc immunoprecipitation of dP32-EGFP was ob-
served (Figure 6A). These immunoprecipitates were examined for
co-IP of endogenous dP32 as an indication of homomeric interactions
of dP32. Speciﬁc co-IP of endogenous dP32 was observed in samples
from ﬂies expressing dP32-EGFP but not in wild-type control samples
(Figure 6B). These results conﬁrm homomeric interactions of dP32.
Preservation of presynaptic organization in the
dp32EC1 mutant
As a ﬁrst step in examining the possible functions of dP32 in synaptic
transmission, basic synaptic morphology was assessed in the dp32EC1
mutant. Although it was considered unlikely that enhancement of the
cacTS2 synaptic phenotype by dp32EC1 was associated with changes in
the morphology of presynaptic terminals, immunocytochemical analysis
of DLM neuromuscular synapses from wild-type or the cacTS2;dp32EC1
double mutant was performed using markers for the neuronal plasma
membrane, the active zone, and synaptic vesicles (Figure S6). These
studies indicated no obvious changes in basic synapse morphology,
including the distributions of active zones and synaptic vesicle clusters.
These observations are consistent with the lack of a synaptic phenotype
at a permissive temperature and suggest that loss of dP32 protein
produces a TS functional defect at morphologically normal synapses.
Finally, synaptic organization was examined with respect to the
distribution of presynaptic mitochondria, which is altered in several
Drosophila mutants (Guo et al. 2005; Stowers et al. 2002; Verstreken
et al. 2005). To investigate whether dP32 plays a role in mitochondrial
transport or localization, immunocytochemical analysis of mito-
DsRed localization with respect to an active zone marker was exam-
ined at DLM neuromuscular synapses of wild-type and dp32EC1 after
exposure to a restrictive temperature of 36 . At both wild-type and
mutant synapses, mitochondria were associated with most active
Figure 4 Western analysis and transformation rescue conﬁrm that
e(cac)2902 is dp32. (A) Western analysis of ﬂy head homogenates pre-
pared from WT and dp32EC1, as well as the dp32EC1 mutant express-
ing wild-type dP32 in the nervous system (dp32EC1/Df rescue). A
prominent band at  26 kD is recognized by an anti-dP32 antibody.
This band is absent in the mutant and elevated after neural expression
of UAS-dp32 in the dp32EC1 mutant. Tubulin (TUB) was used as an
internal loading control. (B) Presynaptic expression of wild-type dP32
rescues the dp32EC1 paralytic phenotype. Behavioral data for WT and
dp32EC1/Df are the same as those shown in Figure 1. Behavioral tests
were truncated after 20 min. These results conﬁrm that TS paralysis in
dp32EC1 results from disruption of dP32.
Figure 5 Localization of dP32 in mitochondria at DLM neuromuscular synapses. (A–E) Confocal immunoﬂuorescence and native EGFP and DsRed
ﬂuorescence images of adult DLM neuromuscular synapses exhibiting neuronal (presynaptic) expression of dP32-EGFP and mito-DsRed. Mito-
DsRed serves as a marker for mitochondria. Anti-HRP labels the neuronal plasma membrane. Colocalization of dP32-EGFP and mito-DsRed
demonstrates a mitochondrial distribution for dP32.
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synaptic mitochondria in the dp32EC1 mutant.
Possible functional roles of dP32 in
synaptic transmission
The preceding ﬁndings indicate that basic synapse morphology and
localization of presynaptic mitochondria is normal in the dp32EC1
mutant. These ﬁndings, together with the observed mitochondrial
localization of dP32, suggest that dP32 plays an important physiolog-
ical role in mitochondria to support the function of established syn-
apses. Three key aspects of mitochondrial function were considered:
the mitochondrial membrane potential, ATP production, and mito-
chondrial calcium signaling.
Mitochondrial membrane potential and ATP synthesis
The membrane potential maintained across the inner mitochondrial
membrane participates in several aspects of mitochondrial function
and is essential for ATP production. As described in the following
text, these critical aspects of mitochondrial function might be altered
in the dP32 mutant and lead to disruption of synaptic transmission.
The dP32EC1 mutant exhibits a wild-type mitochondrial membrane
potential (DCm): Previous studies have disrupted the membrane
potential of presynaptic mitochondria and examined its contribution to
synaptic transmission (Billups and Forsythe 2002). This work revealed
that loss of DCm produces a stimulation-dependent reduction in neu-
rotransmitter release. A possible role for dP32 in maintaining DCm
was examined using the ﬂuorescent indicator tetramethylrhodamine
ethyl ester (TMRE). Accumulation of TMRE in mitochondria is related
to DCm and may be used to determine changes in DCm as described
previously (Twig et al. 2006). The relative mitochondrial DCmw a s
examined by comparing ﬂuorescence intensities at wild-type and
dP32EC1 DLM neuromuscular synapses after exposure to TMRE for
10 min. As in previous work (Twig et al. 2006), the mitochondrial
TMRE ﬂuorescence intensity was normalized to a GFP-based mito-
chondrial marker, mito-GFP, to control for differences in the size and
shape of the mitochondria in each optical section. Studies carried out at
both 20  and the restrictive temperature of 36  indicated that dP32EC1
exhibits a wild-type DCm (Figure 8, A and B).
Head homogenates from dP32EC1 contain wild-type levels of ATP:
Mitochondrial ATP production plays a key role in providing energy
for synaptic function. Previous work in Drosophila indicates that stress
sensitive B, a mitochondrial protein, contributes to synaptic transmis-
sion through the generation of ATP (Rikhy et al. 2003; Trotta et al.
2004). To examine whether dP32 functions in this process, ATP levels
were measured in homogenized head tissue from wild-type and
dP32EC1 mutant ﬂies. These studies employed a luciferin-luciferase
ATP assay as described previously (Al-Anzi et al. 2009; Liu et al.
2007; Park et al. 2006). ATP measurements carried out on homoge-
nates from ﬂies exposed to the restrictive temperature of 38  indicated
no signiﬁcant difference between wild-type controls and the dP32EC1
mutant (Figure 8C). These observations represent a global analysis of
brain tissue, including central synapses. Although they provide strong
evidence against a role for dP32 in ATP production, they cannot
exclude the possibility of local changes in ATP.
The preceding ﬁndings indicate that both mitochondrial DCm
and ATP production persist after loss of dP32 function, and thus,
Figure 6 Homomultimeric interactions of dP32: dP32-EGFP and
endogenous dP32 coimmunoprecipitate from ﬂy head lysate. An
anti-GFP antibody was used to precipitate dP32-EGFP from head
lysate of ﬂies expressing dP32-EGFP in the nervous system or control
ﬂies (WT) lacking the transgene. Immunoprecipitation (IP) of dP32-
EGFP (A) and co-IP of endogenous dP32 (B) was demonstrated by
Western blotting using anti-GFP and anti-dP32 antibodies, respec-
tively. Speciﬁc co-IP of dP32 was observed only in samples expressing
dP32-EGFP, indicating homomultimeric association of dP32-EGFP and
endogenous dP32 subunits.
Figure 7 Wild-type presynaptic distri-
bution of mitochondria in the dp32EC1
mutant. Confocal images of adult DLM
neuromuscular synapses expressing
mito-DsRed in WT (A–E) and the w;
dp32EC1/ Df(2R)14F06W-07 mutant
(dp32EC1) (F–J). Dissected prepara-
tions were exposed to a restrictive tem-
perature of 36  for 7 min and then ﬁxed
and processed for immunocytochemis-
try. Mitochondria were visualized by na-
tive mito-DsRed ﬂuorescence. Anti-HRP
and anti-BRP label the neuronal plasma
membrane and presynaptic active
zones, respectively. The presence of
presynaptic mitochondria adjacent to
active zones was observed in both
wild-type and mutant nerve terminals.
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critical aspects of mitochondrial function.
Possible role for dP32 in mitochondrial calcium signaling
Because mitochondria sequester and release calcium within the
presynaptic terminal, they can play important roles in regulation of
cytosolic calcium, calcium-dependent neurotransmitter release, and
synaptic plasticity (Billups and Forsythe 2002; David and Barrett 2003;
Tang and Zucker 1997; Yang et al. 2003). In light of the observed role
for dP32 in neurotransmitter release, a function for this protein in
presynaptic calcium signaling was examined.
dP32EC1 exhibits a conditional increase in presynaptic calcium
with respect to wild-type: Measurement of cytosolic calcium tran-
sients elicited by synaptic stimulation was carried out through
transgenic expression of the GFP-based calcium indicator GCaMP3
in the nervous system (Tian et al. 2009) (Figure 9, A–F). This approach
was used to compare presynaptic calcium transients at wild-type or
dP32EC1 mutant DLM neuromuscular synapses. At 20 ,4 0H zs t i m u -
lation (200 pulses) of wild-type and mutant synapses produced similar
calcium transients (Figure 9, C and E). As described previously for
GCaMP1.3 and GCaMP1.6 measurements of presynaptic calcium tran-
sients (Reiff et al. 2005), synaptic stimulation elicits an initial peak in
the ﬂuorescence intensity, followed by a gradual decline during the
stimulation train, and an undershoot phase after stimulation. To ex-
amine a possible conditional phenotype in dP32EC1, analogous calcium
imaging experiments were carried out at 33 .A tt h i st e m p e r a t u r e ,
dP32EC1 enhances the cacTS2 synaptic phenotype (Figure 2) but does
not have a strong synaptic phenotype in a cac+ background. Attempts
to image calcium transients at 36 ,a tw h i c hdP32EC1 has a clear syn-
aptic phenotype in the absence of cacTS2, were unsuccessful due to
motion artifacts in the DLM neuromuscular synapse preparation at
this temperature. Nonetheless, a conditional dP32EC1 phenotype was
observed at 33 . At this temperature, the calcium transient elicited by
40 Hz stimulation was increased in dP32EC1 with respect to wild-type
(Figure 9, D and F). This observation was surprising, given that
dP32EC1 produces a conditional decrease in calcium-triggered neuro-
transmitter release. These ﬁndings indicate a role for dP32 in regulating
presynaptic calcium transients during synaptic activity and suggest that
dP32 functions in mitochondrial calcium signaling (see Discussion).
The preceding results raised the possibility that elevated resting
presynaptic calcium in dP32EC1 might impair neurotransmitter release.
Thus, additional experiments were carried out to assess resting presyn-
aptic calcium concentrations. These studies employed the ratiometric
calcium indicator yellow cameleon 3.6 (YC3.6) (Nagai et al. 2004) to
determine relative resting presynaptic calcium concentrations at wild-
type and dP32EC1 synapses. These experiments were carried out at 20 ,
33 ,a n d3 6  , the latter feasible because of the short time-lapse imaging
periods (5 sec) required for imaging resting calcium. At 20 ,n os i g n i f -
icant difference was observed in the resting presynaptic calcium con-
centration at wild-type and dP32EC1 synapses (Figure 9, G and H). In
contrast, resting calcium was increased in dP32EC1 relative to wild-type
at elevated temperatures (Figure 9, G and H). This relative increase in
resting calcium in dP32EC1 was signiﬁcant at 36 . It is interesting to
consider whether this conditional increase in cytosolic calcium in
dP32EC1 might impair evoked neurotransmitter release (see Discussion).
DISCUSSION
We conducted a genetic screen for synaptic transmission mutants in
Drosophila and isolated a new mutation in a Drosophila homolog of
the mitochondrial protein P32, which represents the ﬁrst P32 muta-
tion in a multicellular organism. Although P32 is highly conserved
and has been studied extensively, its physiological function in mito-
chondria remains unknown. This new mutant, referred to as dP32EC1,
exhibited a temperature-sensitive (TS) paralytic behavioral phenotype.
Moreover, electrophysiological analysis at adult neuromuscular syn-
apses revealed a TS reduction in neurotransmitter release, indicating
that dP32 serves an important function in synaptic transmission. Our
immunocytochemical analysis has shown that dP32 is located within
presynaptic mitochondria, which are known to be important in ATP
production and calcium signaling at synapses. Furthermore, the basic
molecular and structural organization of synapses appears to be nor-
mal in the dP32 mutant, suggesting a direct role for this protein in
synaptic function. At the molecular level, our biochemical studies in-
dicated conserved homomultimeric interactions of dP32 subunits.
Finally, assessment of presynaptic mitochondrial function was exam-
ined in the dP32 mutant through measurement of ATP levels and
imaging studies of mitochondrial membrane potential and presynap-
tic calcium. This work indicated that mitochondrial ATP production
and membrane potential in the dP32 mutant resembled wild-type,
Figure 8 dp32EC1 mutant retains wild-type mitochon-
drial membrane potential (DCm) and ATP production.
(A, B) DCm measurements using tetramethylrhodamine
ethyl ester perchlorate (TMRE) and GFP targeted to the
mitochondrial matrix (mito-GFP). (A) Examples of live
confocal images of TMRE at DLM neuromuscular synap-
ses exhibiting neuronal expression of UAS-mito-GFP in
aW To rdp32EC1 genetic background. Mito-GFP serves
as a mitochondrial marker within presynaptic terminals.
(B) dp32EC1 retains wild-type DCm. The ratio of TMRE
to GFP (TMRE/GFP) from the same region of interest
was used to represent the relative DCm, which should
be independent of mitochondrial size, shape, and ori-
entation. The relative DCm from dp32EC1 is shown as
a mean percentage of that from WT. The DCmi n
dp32EC1 is not signiﬁcantly different from WT at either
temperature. The respective ratios of TMRE to GFP at
WT and dp32EC1 synapses were 1.32 6 0.11 (n ¼ 26) and 1.30 6 0.11 (n ¼ 23) at 20 . The corresponding values at 36  were 0.60 6 0.06 (n ¼ 22)
and 0.56 6 0.05 (n ¼ 24). (C) Head homogenates from dp32EC1 contain wild-type levels of ATP. Head homogenates prepared from WT and
dp32EC1 ﬂies were exposed to 38  for 10 min and subjected to a luciferin-luciferase ATP detection assay. The relative ATP levels were calculated
by dividing the luminescence by the total protein concentration. The relative ATP levels in WT and dp32EC1 were 1.28 6 0.24 nmol/mg protein
(n ¼ 5) and 1.27 6 0.23 nmol/mg protein (n ¼ 5), respectively, and not signiﬁcantly different.
66 | A. Lutas et al.whereas the mutant exhibited a TS increase in both resting and evoked
presynaptic calcium concentration. Taken together, the preceding
ﬁndings reveal a role for dP32 in synaptic transmission and mito-
chondrial regulation of presynaptic calcium.
Molecular properties of dP32
Mitochondrial localization of P32 proteins involves an N-terminal
targeting domain that is cleaved from the mature targeted protein
(Honoré et al. 1993). Comparison of Drosophila and vertebrate P32
sequences indicates conservation of the proteolytic cleavage site in
dP32 (Figure 3B). In the present study, an equivalent targeting func-
tion for the N-terminal domain of dP32 was demonstrated through its
ability to mediate mitochondrial targeting. When the ﬁrst 71 amino
acids of dP32, including the proteolytic cleavage site, was fused to
GCaMP3, this fusion protein (mito-GCaMP3) was efﬁciently targeted
to mitochondria (see Materials and Methods and Figure S2). Although
only modest sequence conservation was observed between the N-
terminal domains of dP32 and vertebrate P32 proteins (Figure 3B),
previous studies suggest that mitochondrial targeting domains vary
in amino acid sequence but often share an amphipathic helical struc-
ture [reviewed in Chacinska et al. (2009)].
Structural studies have established that P32 is a homotrimer in
which monomers are arranged around a central pore in a donut-like
structure. In the present study, homomultimerization of dP32
subunits was demonstrated in co-immunoprecipitation experiments
(Figure 6). The trimeric structure of P32 exhibits a highly asymmetric
Figure 9 dp32EC1 exhibits conditional defects
in presynaptic calcium signaling. (A–F) Imaging
of cytosolic calcium transients within DLM neu-
romuscular presynaptic terminals expressing
the calcium indicator GCaMP3. (A) A represen-
tative image of GCaMP3 at a resting WT syn-
apse at 20 . Neuronal expression of the
membrane-associated mCD8-mRFP protein
provided a red ﬂuorescent marker for nerve
terminals. (B) Example images of GCaMP3 at
WT synapses before, during, and after DLM
motor axon stimulation (40 Hz for 5 sec) at
20 . Times indicated are relative to the start
of the time-lapse imaging, and axon stimula-
tion was initiated at 5 sec. (C–F) Fluorescence
changes (DF/F) were examined at WT and
dp32EC1 (dp32EC1/Df) synapses. (C) At 20 ,
DLM motor axon stimulation at 40 Hz for 5 s
(bar above X axis) produced a similar increase
in cytosolic calcium at WT (n ¼ 11) and
dp32EC1 (n ¼ 17) synapses. In contrast, the
same stimulation protocol at 33  (D) elicited
a larger calcium transient in dp32EC1 (n ¼ 13)
than in WT (n ¼ 14). The peak DF/F in dp32EC1
(3.09 6 0.22) was signiﬁcantly increased with
respect to WT (2.48 6 0.22). The data shown
in C and D were normalized to the maximum
DF/F in WT at each temperature and replotted
in E and F, respectively. Asterisks in D and F
indicate that the maximum DF/F in dp32EC1 is
signiﬁcantly greater than that in WT. (G, H)
Imaging of relative resting presynaptic calcium
concentrations within DLM neuromuscular pre-
synaptic terminals expressing the ratiometric
calcium indicator Cameleon YC3.6. The
EYFP/ECFP emission ratio (YFP/CFP) was used
to assess the relative resting presynaptic cal-
cium concentrations at WT and dp32EC1
(dp32EC1/Df) synapses at 20 ,3 3  , and 36 
(G). (H) The data shown in G were normalized
to the mean YFP/CFP ratio in WT at each tem-
perature. At restrictive temperatures, resting
calcium was increased in dp32EC1 with respect
to WT. As a percentage of WT, the resting
calcium concentration at dp32EC1 synapses at
20  was 93 6 4% (WT, n ¼ 17; dp32EC1,n¼
11). The corresponding values at 33  and 36 
were 107 6 4% (WT, n ¼ 12; dp32EC1,n¼ 12)
and 109 6 2% (WT, n ¼ 13; dp32EC1,n¼ 9),
respectively.
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residues along one side of the donut, raising the possibility that P32
may participate in calcium binding within the mitochondrial matrix
(Jiang et al. 1999). Notably, ﬁve residues that are spatially clustered to
form a pocket on the negatively charged side of human P32, Glu-89,
Leu-231, Asp-232, Glu-264, and Tyr-268, are identical in the Drosoph-
ila protein. Further genetic analysis may address the importance of
these clustered residues in dP32 function at synapses.
Possible mechanism of dP32 function in
neurotransmitter release
In the present study, several possible mechanisms of dP32 function in
mitochondria and synaptic transmission were considered and in-
vestigated, most notably possible roles in supporting mitochondrial
membrane potential, ATP production, and presynaptic calcium
signaling. Among these, our observations favor a function for dP32
in mitochondrial mechanisms regulating presynaptic calcium. Al-
though neurotransmitter release was reduced at restrictive temper-
atures in dP32EC1, the presynaptic calcium concentration was
increased both at rest and in response to synaptic stimulation. It is
of interest to consider why the increase in presynaptic calcium in
dP32EC1 is TS in what appears to be a complete loss-of-function
mutant. Previous studies at Drosophila larval neuromuscular synapses
at elevated temperatures have observed a TS increase in resting cyto-
solic calcium and associated inhibition of neurotransmitter release
(Klose et al. 2009). This calcium increase was enhanced by pharma-
cological inhibition of presynaptic calcium clearance mechanisms or
genetic removal of presynaptic mitochondria, but it remained depen-
dent on temperature. The present ﬁndings may reﬂect a similar TS
process involving calcium-dependent inhibition of neurotransmitter
release and dP32-dependent mitochondrial mechanisms. Efforts to
further address these mechanisms were pursued by employing a cal-
cium indicator targeted to the mitochondrial matrix, mito-GCaMP3
(see Materials and Methods and Figure S2). Although this approach
was successful for imaging mitochondrial calcium transients elicited
by motor axon stimulation in both WT and dP32EC1 at 20  (Figure
S7), robust calcium transients could not be observed in either geno-
type when the temperature was increased to the restrictive temper-
atures of 33  or 36 .
The preceding observations suggest that sustained elevation of
presynaptic calcium in the dP32 mutant may lead to reduced
neurotransmitter release. Such a calcium-dependent mechanism has
been reported previously in the squid giant synapse and attributed to
calcium-dependent adaptation of the neurotransmitter release appa-
ratus (Hsu et al. 1996). Understanding the precise mechanism by
which loss of dP32 impairs neurotransmitter release will require fur-
ther investigation. One interesting question is how the absence of
dP32 in the mitochondrial matrix leads to increased presynaptic cal-
cium and whether this reﬂects the putative calcium binding capacity
of this protein. Finally, while the present study is focused on the newly
discovered role for P32 in neurotransmitter release, the resulting re-
search materials are expected to facilitate in vivo analysis of P32
function in a broad range of biological processes.
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